newsfilter
← Latest News
GlobeNewswire·

PharmaTher Receives US FDA Approval Goal Date for Ketamine

TORONTO, March 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB:PHRRF) (CSE:PHRM), a specialty pharmaceutical company hyper-focused on the commercialization of Ketamine, is